Compare Pharmacogenomics Testing Options
Several approaches to pharmacogenomic testing exist — from clinician-ordered panel tests to services that analyze DNA data you already have. The comparisons below break down how they work, what clinical frameworks they use, and how they differ in accessibility and cost.
For background on the science behind these tests, see our educational articles and methodology page. You can also read about DecodeMyBio to understand our approach. For guidance on how methylation testing complements pharmacogenomic assessment, see our methylation testing guide.
For a consolidated guide covering GeneSight pricing, insurance coverage, clinical evidence, and alternatives in one place, see our independent GeneSight cost, insurance & alternatives guide.
Comparisons
GeneSight vs 23andMe: Which Is Better for Pharmacogenomics?
Side-by-side comparison of GeneSight clinical testing vs 23andMe raw data analysis — cost, gene coverage, accuracy, turnaround, and when each approach makes sense for your situation.
9 min read · Last updated April 2026
Pharmacogenomic Testing vs 23andMe: What's the Difference?
Clinical pharmacogenomic testing and 23andMe serve different purposes. How they compare on cost, accuracy, gene coverage, and when to use each for medication insights.
8 min read · Last updated April 2026
Best 23andMe Raw Data Analysis Tools (2026)
Compare the top tools for analyzing your 23andMe raw data — health reports, pharmacogenomics, ancestry deep-dives, and trait analysis. What each tool covers, pricing, and limitations.
10 min read · Last updated April 2026
GeneSight Alternative: Pharmacogenomics from Your Existing DNA
Compare clinician-ordered pharmacogenomic tests (GeneSight, Genomind) with raw data analysis services (SelfDecode, DecodeMyBio). Side-by-side feature table, clinical framework differences, and guidance on choosing the right approach.
7 min read · Last updated February 2026
GeneSight vs Genomind 2026: Which Is Worth the Money?
Head-to-head comparison of GeneSight (15 genes) and Genomind Professional PGx Express (26 genes) — pricing, clinical trial evidence, FDA context, and the raw data alternative.
8 min read · Last updated March 2026
GeneSight Really Costs $330 — Here's How to Pay $0 (or $49)
GeneSight costs $330 self-pay. Medicare Part B typically covers it at $0. Includes the 2025 UnitedHealthcare policy change and lower-cost alternatives like raw data analysis.
7 min read · Last updated March 2026
GeneSight Reviews: What Patients Report
Balanced summary of patient experiences, clinical trial evidence, common criticisms, cost context, and how GeneSight compares to raw data analysis alternatives.
8 min read · Last updated March 2026
Ready to see your results?
Upload your 23andMe or AncestryDNA file and get your report in minutes.
Get Started Free